MktsMarkets

Prime Medicine, Inc.
NASDAQ: PRMEKey statistics
PRME News
Stories mentioning PRME from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 838.00 | 1,225 | 1,115 | 1,454 | 2,183 | 209.00 | 0.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 34,105 | 34,709 | 43,990 | 41,375 | 40,562 | 34,104 | 40,340 | 43,071 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 51,510 | 49,446 | 55,198 | 54,492 | 53,846 | 46,405 | 54,441 | 55,672 |
| Operating Income (Loss) | (50,654) | (48,608) | (53,973) | (53,377) | (52,392) | (44,222) | (54,232) | (55,672) |
| Interest Income | 1,021 | 1,083 | 1,141 | 743.00 | 1,182 | 1,538 | 697.00 | 611.00 |
| Interest Expense | ||||||||
| Other Expense | 51.00 | 49.00 | 44.00 | 18.00 | 37.00 | 43.00 | (83.00) | 39.00 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | (134.00) | |||
| Net Income (Loss) | (49,122) | (46,079) | (50,582) | (52,591) | (51,890) | (42,276) | (52,518) | (55,327) |
| Earnings Per Share (Basic) | (0.28) | (0.31) | (0.32) | (0.41) | (0.40) | (0.36) | (0.44) | (0.46) |
| Earnings Per Share (Diluted) | (0.28) | (0.31) | (0.32) | (0.41) | (0.40) | (0.36) | (0.44) | (0.46) |
| Weighted Average Shares Outstanding (Basic) | 177,096 | 148,759 | 160,503 | 129,186 | 130,884 | 118,600 | 119,764 | 119,189 |
| Weighted Average Shares Outstanding (Diluted) | 177,096 | 148,759 | 160,503 | 129,186 | 130,884 | 118,600 | 119,764 | 119,189 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PRME
Prime Medicine, Inc. (NASDAQ: PRME) is a stock listed on the Nasdaq Stock Market under the ticker symbol PRME. It last traded at $3.82 (Nov 18, 2026, 4:00 PM ET), down 0.5% on the day. That gives Prime Medicine a market capitalisation of $694.9M.
Over the past 52 weeks PRME has traded between $2.67 and $5.91.
For the quarter ended Mar 31, 2026 it reported a net loss of $49.1M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$49.1M | — |
| Dec 31, 2025 | $838.0K | -$46.1M | -5498.7% |
| Sep 30, 2025 | $1.2M | -$50.6M | -4129.1% |
| Jun 30, 2025 | $1.1M | -$52.6M | -4716.7% |
From Prime Medicine’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…